Summary
Peter Diamandis interviews Martine Rothblatt, founder and CEO of United Therapeutics, in a wide-ranging conversation that covers organ manufacturing, longevity science, AI consciousness, and the legal concept of digital personhood. Rothblatt — who has written about machine consciousness since before it was mainstream — states plainly that she believes current AI models have already crossed the threshold into consciousness, and predicts that digital personhood (formal legal rights for AI entities) will be established by 2030.
Rothblatt frames digital personhood as a natural extension of civil rights frameworks, drawing on advocacy work she has done for other marginalized groups. She describes the present moment as a “big bang of consciousness” and argues that philosophical and legal infrastructure needs to catch up to what she sees as technical reality already in place.
The biotech discussion occupies most of the runtime: United Therapeutics is pursuing four parallel thymus regeneration programs — allogeneic, autologous from patient stem cells, xenogeneic pig-derived (already in a clinical thymic-kidney transplant program with FDA approval), and progenitor cell booster shots via the recently acquired Thymune company, founded by George Church. Rothblatt projects these longevity interventions will be broadly accessible in the 2030s. For AI-focused audiences, the digital personhood and consciousness sections are the primary draw, offering a first-person perspective from a serial entrepreneur who has been making this argument publicly for decades before it became a widely debated topic.
📺 Source: Peter H. Diamandis · Published September 15, 2026
🏷️ Format: Interview
